ロード中...
VSL#3 induces and maintains short-term clinical response in patients with active microscopic colitis: a two-phase randomised clinical trial
BACKGROUND: The probiotic mixture VSL#3 has proven efficacious in inflammatory bowel diseases and irritable bowel syndrome; however, its efficacy in microscopic colitis (MC) is being investigated. OBJECTIVE: To evaluate the safety and efficacy of a multistrain probiotic, VSL#3, in inducing clinical...
保存先:
| 出版年: | BMJ Open Gastroenterol |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4599154/ https://ncbi.nlm.nih.gov/pubmed/26462271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjgast-2014-000018 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|